Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share




2007 (EN)
Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer (EN)

Sklavaina Maria,
Triantafillidis J.K.,
Konstandellou Evangelia,
Cheracakis P.,
Govosdis V.,
Barbatzas C.,
Tzourmakliotis D.,

SUMMARY Background: Growth hormone (GH), Insulin-like growth factor-I (somatomedine, IGF-I) and gastrin seem to play a significant role in cell proliferation in mamalian and rat cells. The role of these factors in the etiology of gastric and large bowel cancer has not been completely elucitated. The aim of this study was to concurrently estimate the levels of GH, IGF-I and gastrin in a group of patients with gastric and colorectal cancer and to compare the results with those of a group of normal controls. Patients and Methods: In 33 consequtive patients with gastric (16 patients) and large bowel (17 patients) cancer, the serum levels of GH, IGF-I and gastrin were measured by radioimmunoassay. Fiftyfour normal people served as controls. Results: Significantly higher levels of serum GH (3.16�3.12 ng/ml in gastric cancer patients vs 3.01�2.91 ng/ml in colorectal cancer patients vs 0.69�1.60 ng/ml in normal controls, adjusted P (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2007-03-19


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 15, No 1 (2002) (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)